Journal article

Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2

A Reghan Foley, Manoj P Menezes, Amelie Pandraud, Michael A Gonzalez, Ahmad Al-Odaib, Alexander J Abrams, Kumiko Sugano, Atsushi Yonezawa, Adnan Y Manzur, Joshua Burns, Imelda Hughes, B Gary McCullagh, Heinz Jungbluth, Ming J Lim, Jean-Pierre Lin, Andre Megarbane, J Andoni Urtizberea, Ayaz H Shah, Jayne Antony, Richard Webster Show all

Brain | OXFORD UNIV PRESS | Published : 2014

Grants

Awarded by National Institutes of Health


Awarded by Medical Research Council: MRC


Awarded by MRC neuromuscular centre


Awarded by Ministry of Education, Science, Culture and Sports of Japan


Awarded by Medical Research Council


Awarded by Rosetrees Trust


Awarded by Great Ormond Street Hospital Childrens Charity


Awarded by Muscular Dystrophy UK


Funding Acknowledgements

This work was supported by grants from the National Institute for Health Research UCLH/UCL Comprehensive Biomedical Research Centre; the National Institutes of Health [R01NS075764-01A1 (S.Z.), R01NS072248 (S.Z.), U54NS065712 (J.B., M. M. R. and S.Z.)]; the Medical Research Council: MRC fellowship G0802760 (H. H.) and MRC neuromuscular centre grant G0601943; the Wellcome Trust; a grant-in-aid for Scientific Research (KAKENHI) from the Ministry of Education, Science, Culture and Sports of Japan [24590190 (A.Y.), 24590176 (K. M.) and 25136710 (K. M.)]; the Muscular Dystrophy Campaign (A. R. F.), the Thyne Reid Foundation (M. P. M.) and the Great Ormond Street Hospital Children's Charity (F. M., P. C. and S.R.).